Literature DB >> 35851641

Advances in the area of cardiorenal medicine: clinical research highlights from selected papers published in NDT.

Panagiotis I Georgianos1, Rajiv Agarwal2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35851641      PMCID: PMC9395376          DOI: 10.1093/ndt/gfac130

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   7.186


× No keyword cloud information.
  10 in total

1.  Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population.

Authors:  James B Wetmore; Heng Yan; Laura Horne; Yi Peng; David T Gilbertson
Journal:  Nephrol Dial Transplant       Date:  2021-04-26       Impact factor: 5.992

2.  A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk.

Authors:  Carmine Zoccali; Claudia Torino; Francesca Mallamaci; Pantelis Sarafidis; Aikaterini Papagianni; Robert Ekart; Radovan Hojs; Marian Klinger; Krzysztof Letachowicz; Danilo Fliser; Sarah Seiler-Mußler; Fabio Lizzi; Andrzej Wiecek; Agata Miskiewicz; Kostas Siamopoulos; Olga Balafa; Itzchak Slotki; Linda Shavit; Aristeidis Stavroulopoulos; Adrian Covic; Dimitrie Siriopol; Ziad A Massy; Alexandre Seidowsky; Yuri Battaglia; Alberto Martinez-Castelao; Carolina Polo-Torcal; Marie-Jeanne Coudert-Krier; Patrick Rossignol; Enrico Fiaccadori; Giuseppe Regolisti; Thierry Hannedouche; Thomas Bachelet; Kitty J Jager; Friedo W Dekker; Rocco Tripepi; Giovanni Tripepi; Luna Gargani; Rosa Sicari; Eugenio Picano; Gérard Michel London
Journal:  Kidney Int       Date:  2021-08-19       Impact factor: 10.612

3.  Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Rajiv Agarwal; Patrick Rossignol; Alain Romero; Dahlia Garza; Martha R Mayo; Suzette Warren; Jia Ma; William B White; Bryan Williams
Journal:  Lancet       Date:  2019-09-15       Impact factor: 79.321

4.  KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int       Date:  2020-10       Impact factor: 10.612

5.  KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int       Date:  2021-03       Impact factor: 10.612

6.  Can the assessment of ultrasound lung water in haemodialysis patients be simplified?

Authors:  Claudia Torino; Rocco Tripepi; Charalampos Loutradis; Pantelis Sarafidis; Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

7.  Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease.

Authors:  Carl P Walther; Wolfgang C Winkelmayer; Peter A Richardson; Salim S Virani; Sankar D Navaneethan
Journal:  Nephrol Dial Transplant       Date:  2021-09-27       Impact factor: 7.186

8.  The aftermath of coronavirus disease 2019: devastation or a new dawn for nephrology?

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2020-06-01       Impact factor: 5.992

9.  Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.

Authors:  Javed Butler; Stefan D Anker; Tariq Jamal Siddiqi; Andrew J S Coats; Fabio Dorigotti; Gerasimos Filippatos; Tim Friede; Udo-Michael Göhring; Mikhail N Kosiborod; Lars H Lund; Marco Metra; Carol Moreno Quinn; Ileana L Piña; Fausto J Pinto; Patrick Rossignol; Peter Szecsödy; Peter Van Der Meer; Matthew Weir; Bertram Pitt
Journal:  Eur J Heart Fail       Date:  2021-12-09       Impact factor: 17.349

10.  Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trial.

Authors:  Peter Rossing; Jorma Strand; Angelo Avogaro; Michael Becka; Friederike Kanefendt; Christiane Otto
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.